Cover Image
Market Research Report

Self-Administered Ambulatory Subcutaneous Infusion Systems

Published by Greystone Research Associates Product code 929359
Published Content info
Delivery time: 1-2 business days
Back to Top
Self-Administered Ambulatory Subcutaneous Infusion Systems
Published: March 24, 2020 Content info:

Converging Factors Driving the Growth of Subcutaneous Infusion

As currently formulated, a significant number of therapeutic drugs require dosage volumes or possess viscosities well in excess of the upper range for traditional subcutaneous delivery. These drugs are currently delivered via infusion. The demographics of patient populations and the current trend in therapeutic drug development are converging to create an increasingly steep demand curve for infusion. The costs and logistics of this convergence are a major driver of the energy behind small form factor subcutaneous infusion systems. As the adoption of and acceptance of self-administered therapies grows, patients are spending less time with physicians and are playing a greater role in the delivery and management of their treatments. This dramatic shift in healthcare delivery is creating a need for devices that mask an underlying layer of complexity via design initiatives that are patient-friendly.

What You Will Learn:

  • What ambulatory subcutaneous infusion systems are currently marketed or in development, who are the suppliers, and what are the device specifics?
  • What are the therapeutic markets being targeted by ambulatory subcutaneous infusion systems?
  • What are the essential design factors, material selection issues, technologies and market development issues for ambulatory subcutaneous infusion systems?
  • What are the major factors that will drive ambulatory subcutaneous infusion systems demand?
  • What is the addressable market for subcutaneous infusion systems?
  • What is the expected impact of subcutaneous infusion systems on drug delivery markets?
  • Who are the significant players in this segment? What are their strategies? Who are their alliance partners?
Table of Contents
Product Code: SASJ786K

Table of Contents

Executive Summary

Injectable/Infusible Market Segment Dynamics

  • Drug Development Trends
  • Drug Delivery Device Evolution
  • The Trend toward Patient Self-Administration
  • Enabling Technology
  • Lyophilized Drugs/Reconstitution

Subcutaneous Infusion Systems - Design Factors

  • Volumes and Viscosities
  • Primary Packaging
  • Injection Method
  • Device Electronics

Subcutaneous Infusion Devices - Market Segments

  • The Cost and Logistical Burden of Out-patient Infusion
  • Biologicals
  • High Volume Drugs
  • Duration Dependent Administration Drugs

Subcutaneous Infusion Systems Device Analysis

  • enFuse
  • Libertas
  • Evolve
  • SensePatch
  • SmartDose
  • SmartDose Preloaded
  • Unbranded Device
  • Unbranded Device
  • YpsoDose
  • E3D Patch Pump
  • Pod

Market Factors

  • Self-Administration and Patient Compliance
  • Regulatory Guidance and Product Approvals
  • Healthcare Economics
  • Drug Product Differentiation

Market Participant Profiles

Back to Top